Medtronic (NYSE:MDT) underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Insights from analysts’ 12-month price targets are revealed, presenting an average target of $94.73, a high estimate of $106.00, and a low estimate of $85.00. Witnessing a positive shift, the current average has risen by 3.64% from the previous average price target of $91.40. Exploring Ana…